Advanced Synthesis & Catalysis
10.1002/adsc.201901299
7
1
.25 (s, 1H), 7.20 (d, J = 2.3 Hz, 1H), 7.18 (d, J = 2.3 Hz, (t, J = 7.3 Hz, 1H), 7.55-7.53 (m, 2H), 7.42 (s, 1H), 7.22 (s,
H), 7.12 (d, J = 2.3 Hz, 1H), 6.25 (t, J = 1.8 Hz, 1H), 6.18 1H), 5.67 (dd, J = 15.5, 6.0 Hz, 1H), 5.54 (dd, J = 15.5, 7.3
(
t, J = 1.8 Hz, 1H), 6.05 (t, J = 1.8 Hz, 1H), 6.02 (t, J = 1.8 Hz, 1H), 4.82 (quint, J = 6.6 Hz, 1H), 3.79 (d, J = 6.9 Hz,
13
Hz, 1H), 4.70-4.63 (m, 1H), 4.32-4.25 (m, 1H), 4.12-4.03 (m, 2H), 1.51 (d, J = 6.9 Hz, 3H); C NMR (CDCl
3
, 100 MHz):
1
1
H), 3.97-3.88 (m, 2H), 3.66-3.58 (m, 1H), 3.43 (dd, J = δ 139.7, 139.7, 137.8, 133.9, 129.2, 128.4, 127.4, 119.1, 93.1,
+
4.6, 3.7 Hz, 1H), 3.38 (dd, J = 14.9, 3.9 Hz, 1H), 2.60-2.30 59.3, 59.1, 19.8; HRMS (ESI) m/z: [M+H] Calcd for
S 355.0116, Found 355.0119.
(
m, 4H), 1.43 (d, J = 6.9 Hz, 3H), 1.34 (d, J = 6.9 Hz, 3H);
14 2 2
C H16BrN O
13
3
C NMR (CDCl , 100 MHz), a 1:1 mixture of
diastereomers: δ 140.7, 140.3, 139.6, 139.3, 139.0, 139.0,
Ethyl
(E)-1-(5-(phenylsulfonyl)pent-3-en-2-yl)-1H-
1
1
4
33.5, 133.5, 131.4, 129.8, 128.2, 127.6, 127.5, 127.5, 105.4,
05.3, 105.3, 104.8, 60.1, 59.4, 54.2, 54.2, 53.8, 53.8, 42.4,
pyrazole-4-carboxylate (3f). Compound 3f was
synthesized from 1H-pyrazole-4-carboxylate (2f, 40.0 mg,
+
1.6, 21.9, 20.5; HRMS (ESI) m/z: [M+H] Calcd for
0
.300
mmol)
and
(((1E,3E)-penta-1,3-dien-1-
C
17
H
21
N
4
O
2
S 345.1385, Found 345.1386.
yl)sulfonyl)benzene (1, 75.0 mg, 0.360 mmol) in 79% yield
82.6 mg, 0.237 mmol) as ivory solid. The crude product was
purified using silica gel column chromatography
(
(
E)-4-Methyl-1-(5-(phenylsulfonyl)pent-3-en-2-yl)-1H-
pyrazole (3b). Compound 3b was synthesized from 4- (EtOAc:hexanes = 1:1). mp 82-83 °C; IR (neat): 3124 (w),
methyl-1H-pyrazole (2b, 24.6 mg, 0.300 mmol) and 2978 (w), 1705 (s), 1551 (m), 1443 (m), 1404 (m), 1304 (s),
-
1
(
((1E,3E)-penta-1,3-dien-1-yl)sulfonyl)benzene (1, 75.0 mg, 1219 (s), 1180 (s), 1142 (s), 1026 (s), 980 (m), 771 (s) cm ;
1
0
.360 mmol) in 90% yield (78.0 mg, 0.269 mmol) as light
3
H NMR (CDCl , 400 MHz): δ 7.85 (s, 1H), 7.80 (s, 1H),
yellow oil. The crude product was purified using silica gel 7.77 (d, J = 7.8 Hz, 2H), 7.62 (t, J = 7.8 Hz, 1H), 7.51 (t, J
column chromatography (EtOAc:hexanes = 1:1). IR (neat): = 7.8 Hz, 2H), 5.69 (dd, J = 15.3, 6.4 Hz, 1H), 5.54 (dt, J =
3
9
070 (w), 2978 (w), 1628 (m), 1450 (m), 1311 (s), 1149 (s), 15.3, 7.4 Hz, 1H), 4.85 (quint, J = 6.6 Hz, 1H), 4.28 (q, J =
-1 1
3
80 (m), 910 (m), 733 (s) cm ; H NMR (CDCl , 400 MHz): 6.9 Hz, 2H), 3.78 (d, J = 7.4 Hz, 2H), 1.51 (d, J = 6.9 Hz,
13
δ 7.81 (d, J = 7.8 Hz, 2H), 7.63 (t, J = 7.3 Hz, 1H), 7.54-7.50 3H), 1.33 (t, J = 7.1 Hz, 3H); C NMR (CDCl
3
, 100 MHz):
m, 2H), 7.26 (s, 1H), 7.02 (s, 1H), 5.69 (dd, J = 15.6, 6.4 δ 162.8, 140.8, 139.4, 137.8, 133.9, 130.6, 129.1, 128.3,
Hz, 1H), 5.47 (dt, J = 15.6, 7.3 Hz, 1H), 4.77 (quint, J = 6.6 119.2, 115.0, 60.1, 59.2, 59.0, 19.9, 14.3; HRMS (ESI) m/z:
(
+
Hz, 1H), 3.77 (d, J = 7.3 Hz, 2H), 2.03 (s, 3H), 1.47 (d, J = [M+H] Calcd for C17
H
21
N
2
O
4
S 349.1222, Found 349.1222.
13
6
1
1
2
3
.9 Hz, 3H); C NMR (CDCl , 100 MHz): δ 140.8, 139.4,
37.9, 133.7, 129.0, 128.4, 125.9, 117.9, 115.9, 59.3, 58.1,
(
(
E)-1-(5-(Phenylsulfonyl)pent-3-en-2-yl)-1H-imidazole
3g). Compound 3g was synthesized from 1H-imidazole (2g,
+
19 2 2
9.9, 8.8; HRMS (ESI) m/z: [M+H] Calcd for C15H N O S
91.1167, Found 291.1168.
2
0.4 mg, 0.300 mmol) and (((1E,3E)-penta-1,3-dien-1-
yl)sulfonyl)benzene (1, 75.0 mg, 0.360 mmol) in 75% yield
(62.5 mg, 0.226 mmol) as yellow oil. The crude product was
(
E)-3,5-Dimethyl-1-(5-(phenylsulfonyl)pent-3-en-2-yl)-
1
H-pyrazole (3c). Compound 3c was synthesized from 3,5- purified using silica gel column chromatography (10%
dimethyl-1H-pyrazole (2c, 28.8 mg, 0.300 mmol) and MeOH in EtOAc). IR (neat): 3078 (w), 2986 (w), 1643 (w),
(
-
1 1
((1E,3E)-penta-1,3-dien-1-yl)sulfonyl)benzene (1, 75.0 mg, 1497 (m), 1304 (s), 1142 (s), 910 (m), 741 (s) cm ; H NMR
0
3
.360 mmol) in 71% yield (65.0 mg, 0.213 mmol) as an (CDCl , 400 MHz): δ 7.75 (d, J = 7.8 Hz, 2H), 7.61 (t, J =
ivory solid. The crude product was purified using silica gel 7.3 Hz, 1H), 7.51-7.47 (m, 2H), 7.34 (s, 1H), 6.97 (s, 1H),
column chromatography (EtOAc:hexanes = 1:1). mp 91- 6.74 (s, 1H), 5.62 (dd, J = 15.3, 6.0 Hz, 1H), 5.44 (dt, J =
9
1
(
2 °C; IR (neat): 2955 (w), 2878 (w), 1551 (w), 1443 (m), 15.3, 7.4 Hz, 1H), 4.66 (quint, J = 6.6 Hz, 1H), 3.75 (d, J =
-
1
1
1
3
296 (s), 1142 (s), 1080 (m), 980 (m), 733 (s) cm ; H NMR 7.4 Hz, 2H), 1.44 (d, J = 6.9 Hz, 3H); C NMR (CDCl
3
, 100
CDCl
3
, 400 MHz): δ 7.76 (d, J = 7.8 Hz, 2H), 7.59 (t, J = MHz): δ 140.1, 137.8, 135.2, 133.8, 129.1, 128.1, 127.3,
+
7
1
.3 Hz, 1H), 7.50-7.46 (m, 2H), 5.74 (s, 1H), 5.69 (dd, J = 118.5, 116.9, 58.9, 53.7, 20.4; HRMS (ESI) m/z: [M+H]
5.6, 5.9 Hz, 1H), 5.31 (dt, J = 15.6, 7.6 Hz, 1H), 4.66 (quint, Calcd for C14 S 277.1011, Found 277.1012.
17 2 2
H N O
J = 6.7 Hz, 1H), 3.72 (d, J = 7.6 Hz, 2H), 2.15 (s, 3H), 2.14
1
3
(
s, 3H), 1.46 (d, J = 6.9 Hz, 3H); C NMR (CDCl
3
, 100
(
E)-4-Methyl-1-(5-(phenylsulfonyl)pent-3-en-2-yl)-1H-
MHz): δ 147.2, 141.1, 138.2, 137.9, 133.6, 128.9, 128.3,
imidazole (3h). Compound 3h was synthesized from 4-
methyl-1H-imidazole (2h, 24.6 mg, 0.300 mmol) and
1
16.9, 105.1, 59.3, 54.4, 19.8, 13.5, 10.8; HRMS (ESI) m/z:
+
[
21 2 2
M+H] Calcd for C16H N O S 305.1324, Found 305.1324.
(
((1E,3E)-penta-1,3-dien-1-yl)sulfonyl)benzene (1, 75.0 mg,
.360 mmol) in 80% yield (70.0 mg, 0.241 mmol) as yellow
0
(
E)-4-Chloro-1-(5-(phenylsulfonyl)pent-3-en-2-yl)-1H-
oil. The crude product was purified using silica gel column
pyrazole (3d). Compound 3d was synthesized from 4- chromatography (10% MeOH in EtOAc). IR (neat): 3109
chloro-1H-pyrazole (2d, 30.8 mg, 0.300 mmol) and (w), 2978 (w), 1643 (m), 1450 (m), 1304 (s), 1149 (s), 910
-
1 1
(
3
((1E,3E)-penta-1,3-dien-1-yl)sulfonyl)benzene (1, 75.0 mg, (m), 733 (s) cm ; H NMR (CDCl , 400 MHz): δ 7.75 (d, J
0
.360 mmol) in 75% yield (70.0 mg, 0.225 mmol) as an = 7.8 Hz, 2H), 7.61 (t, J = 7.3 Hz, 1H), 7.49 (t, J = 7.8 Hz,
ivory solid. The crude product was purified using silica gel 2H), 7.21 (s, 1H), 6.43 (s, 1H), 5.69 (dd, J = 15.6, 5.9 Hz,
column chromatography (EtOAc:hexanes = 1:1). mp 122- 1H), 5.43 (dt, J = 15.6, 7.3 Hz, 1H), 4.56 (quint, J = 6.4 Hz,
1
1
23 °C; IR (neat): 3124 (w), 2993 (w), 1443 (m), 1304 (s), 1H), 3.77 (d, J = 7.3 Hz, 2H), 2.13 (s, 3H), 1.40 (d, J = 7.3
-1 1 13
3 3
142 (s), 972 (m), 741 (s) cm ; H NMR (CDCl , 400 Hz, 3H); C NMR (CDCl ,100 MHz): δ 140.3, 137.8, 134.3,
MHz): δ 7.80 (d, J = 7.3 Hz, 2H), 7.64 (t, J = 7.3 Hz, 1H), 133.7, 129.0, 128.1, 127.3, 118.3, 113.4, 59.0, 53.5, 20.3,
+
7
1
.55-7.51 (m, 2H), 7.36 (s, 1H), 7.19 (s, 1H), 5.66 (dd, J = 13.6; HRMS (ESI) m/z: [M+H] Calcd for C15
5.5, 6.4 Hz, 1H), 5.52 (dt, J = 15.5, 7.6 Hz, 1H), 4.78 (quint, 291.1167, Found 291.1169.
19 2 2
H N O S
J = 6.5 Hz, 1H), 3.78 (d, J = 7.3 Hz, 2H), 1.48 (d, J = 6.9 Hz,
1
3
3
1
H); C NMR (CDCl
3
, 100 MHz): δ 139.7, 137.8, 137.4,
(
E)-1-(5-(Phenylsulfonyl)pent-3-en-2-yl)-1H-
33.9, 129.1, 128.3, 125.3, 119.0, 109.8, 59.2, 59.1, 19.7;
benzo[d]imidazole (3i). Compound 3i was synthesized
from 1H-benzo[d]imidazole (2i, 35.4 mg, 0.300 mmol) and
+
HRMS (ESI) m/z: [M+H] Calcd for C14
H
2
16ClN O
2
S
3
11.0621, Found 311.0623.
(
((1E,3E)-penta-1,3-dien-1-yl)sulfonyl)benzene (1, 75.0 mg,
.360 mmol) in 77% yield (75.6 mg, 0.232 mmol) as ivory
0
(
E)-4-Bromo-1-(5-(phenylsulfonyl)pent-3-en-2-yl)-1H-
oil. The crude product was purified using silica gel column
pyrazole (3e). Compound 3e was synthesized from 4- chromatography (10% MeOH in EtOAc). IR (neat): 3094
bromo-1H-pyrazole (2e, 44.1 mg, 0.300 mmol) and (w), 2986 (w), 1620 (w), 1489 (m), 1311 (s), 1227 (m), 1149
-
1 1
(
3
((1E,3E)-penta-1,3-dien-1-yl)sulfonyl)benzene (1, 75.0 mg, (s), 1088 (m), 910 (s), 741 (s) cm ; H NMR (CDCl , 400
0
.360 mmol) in 86% yield (92.0 mg, 0.259 mmol) as an MHz): δ 7.83-7.80 (m, 1H), 7.77 (s, 1H), 7.68 (d, J = 7.3 Hz,
ivory solid. The crude product was purified using silica gel 2H), 7.56 (t, J = 7.3 Hz, 1H), 7.38 (t, J =7.8 Hz, 2H), 7.31-
column chromatography (EtOAc:hexanes = 1:1). mp 121- 7.30 (m, 3H), 5.77 (dd, J = 15.6, 5.9 Hz, 1H), 5.53 (dtd, J =
1
1
22 °C; IR (neat): 3124 (w), 2986 (w), 1435 (m), 1304 (s), 15.6, 7.3, 1.4 Hz, 1H), 5.01 (quint, J = 6.5 Hz, 1H), 3.78 (d,
-
1
1
1
3
142 (s), 972 (s), 949 (s), 818 (m), 849 (m), 741 (s) cm ; H J = 7.3 Hz, 2H), 1.67 (d, J = 7.3 Hz, 3H); C NMR (CDCl
3
,
NMR (CDCl
3
, 400 MHz): δ 7.81 (d, J = 7.8 Hz, 2H), 7.66 100 MHz): δ 144.0, 140.4, 139.4, 137.8, 133.9, 129.1, 128.2,
7
This article is protected by copyright. All rights reserved.